TAGS: PVC, Plasticizers and Sustainability
The European Pharmacopoeia for the medical and pharmacological industries certifies SIBUR’s Dioctyl terephthalate (DOTP). The certificate allows SIBUR to expand into the segment of medical compounds.
SIBUR’s DOTP Finds Use in Medical Compounds
Mask’s Based-on PVC and DOTP
A Serbian company that is also a customer of SIBUR produces medical compounds for surgical masks to be used by hospital staff treating coronavirus patients. The mask body is made from a medical compound based on SIBUR's
PVC and DOTP. Such masks come with a replaceable filter and can be used up to five times. In May, they have been shipped to the UK, Croatia, Montenegro, Bulgaria and Romania.
Medical Compounds Made Using DOTP
An Eastern European company has set-up one of its production lines to make medical compounds using SIBUR’s DOTP. Following successful tests in a customer laboratory, the compound is now being supplied to ventilator mask manufacturers in Western Europe.
DOTP-based Medical Items and Containers
In Russia, DOTP is replacing DOP
plasticizer due to its superior medical properties, such as zero phthalate content, low volatility, and absence of smell. For example, it is used to make plastic containers for transfusion of blood and its components.
The Russian-made medical compound and items based on it have been certified by the country's Federal Service for Surveillance in Healthcare (Roszdravnadzor), which attests to the high quality of SIBUR's DOTP
plasticizer. Medical items produced in Russia using this
plasticizer have gained incredible traction, especially amid the pandemic. SIBUR plans to promote the use of DOTP in medical items, building on its European success.
Source: SIBUR